Fas- and FasL-deficient mice are resistant to the induction of bleomycin-induced scleroderma

Archives of Dermatological Research

Volumn 298, Issue 9, 2007, Pages 465-468

  Yamamoto, Toshiyuki ^a,b   Yokozeki, Hiroo ^b   Nishioka, Kiyoshi ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bleomycin; Mouse model; Scleroderma

Indexed keywords

BLEOMYCIN; COLLAGEN; FAS LIGAND; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE RESISTANCE; EXPOSURE; FEMALE; HISTOPATHOLOGY; MOUSE; NICK END LABELING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFECT; SCLERODERMA; SKIN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WILD TYPE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD95; APOPTOSIS; BLEOMYCIN; COLLAGEN; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION; IMMUNITY, NATURAL; MICE; MICE, INBRED C3H; MICE, MUTANT STRAINS; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SKIN;

EID: 33846412577     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-006-0712-y     Document Type: Article

References (17)

1. Aoshiba K, Yasui S, Tamaoki J, Nagai A (2000) The Fas/Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 162:695-700
2. Hamilton RF Jr, Li L, Felder TB, Holian A (1995) Bleomycin induces apoptosis in human alveolar macrophages. Am J Physiol 269:L318-L325
3. Hohlbaum AH, Moe S, Marshak-Rothstein A (2000) Opposing effects of transmembrane and soluble Fas-ligand on inflammation and tumor cell survival. J Exp Med 191:1209-1219
4. Jelaska A, Korn JH (2000) Role of apoptosis and transforming growth factor β1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum 43:2230-2239
5. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, Hara N (1999) Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 104:13-19
6. Laplante P, Raymond M-A, Gagnon G, Vigneault N, Sasseville A M-J, Langelier Y, Bernard M, Raymond Y, Hebert M-J (2005) Novel fibrogenic pathwaya are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis. J Immunol 174:5740-5749
7. Nagata S, Golstein P (1995) The Fas death receptor. Science 267:1449-1456
8. Nagata S (1996) Fas ligand and immune evasion. Nat Med 2:1306-1307
9. Omar T, Geraldine P, Belehradek J Jr, Mir LM (1993) Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 53:5462-5469
10. Restifo NP (2000) Not so Fas: re-evaluating the mechanisms of immune privilege and tumor escape. Nat Med 6:493-495
11. Santiago B, Galindo M, Rivero M, Pablos JL (2001) Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts. Arthritis Rheum 44:1667-1676
12. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G (1996) Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 98:785-792
13. Sgonc R, Dietrich H, Sieberer C, Wick G, Christner PJ, Jimenez SA (1999) Lack of endothelial cell apoptosis in the dermis of tight skin 1 and tight skin 2 mice. Arthritis Rheum 42:581-584
14. Siegel RM, Fleisher TA (1999) The role of Fas and related death receptors in autoimmune and other disease states. J Allergy Clin Immunol 103:729-738
15. Yamamoto T, Takagawa S, Katayama I, Yamazaki K, Hamazaki Y, Shinkai H, Nishioka K (1999) Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 112:456-462
16. Yamamoto T, Nishioka K (2004) Possible role of apoptosis in the pathogenesis of bleomycin-induced scleroderma. J Invest Dermatol 122:44-50
17. Yamamoto T, Nishioka K (2005) Increased expression of p53 and p21 (Waf1/Cip1) in the lesional skin of bleomycin-induced scleroderma. Arch Dermatol Res 296:509-513